Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03328104
Title Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma (ENCERT)
Acronym ENCERT
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cincinnati Children's Hospital Cincinnati Ohio 45229 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field